Vestar, Inc.

Company Information

Company Name
Vestar, Inc.
Address
650 Cliffside Drive
San Dimas, CA, 91773
Phone
n/a
URL
n/a
DUNS
n/a
Number of Employees
n/a

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$762,277.00
16
SBIR Phase II
$1,436,043.00
3
Chart code to be here

Award List

  1. THE PROPOSED SBIR PROJECT IS DESIGNED TO DEVELOP AN ASSAY WHICH WILL ALLOW THE DIRECT MEASUREMENT OF A COMMON CARCINOGEN BOUND TO DNA (DNA-ADDUCT) AND ESTABLISH THE CORRELATION BETWEEN THE BURDEN OF THIS ADDUCT AND THE INDUSTRIAL EXPOSURE TO THE

    Amount: $48,911.00

    THE PROPOSED SBIR PROJECT IS DESIGNED TO DEVELOP AN ASSAY WHICH WILL ALLOW THE DIRECT MEASUREMENT OF A COMMON CARCINOGEN BOUND TO DNA (DNA-ADDUCT) AND ESTABLISH THE CORRELATION BETWEEN THE BURDEN OF T ...

    SBIR Phase I 1983 Department of Health and Human Services
  2. PHOSPHOLIPID VESICLES HAVE OFTEN BEEN ACCLAIMED FOR THEIR POTENTIAL AS ANTICANCER DRUG DELIVERY AGENTS.

    Amount: $50,000.00

    PHOSPHOLIPID VESICLES HAVE OFTEN BEEN ACCLAIMED FOR THEIR POTENTIAL AS ANTICANCER DRUG DELIVERY AGENTS. HOWEVER, THERE IS LITTLE EXPERIMENTAL EVIDENCE WHICH CONFIRMS THAT LIPOSOMES ACTUALLY TARGET CHE ...

    SBIR Phase I 1984 Department of Health and Human Services
  3. ENCAPSULATED PARAMAGNETIC IONS TO ENHANCE NMR IMAGING

    Amount: $339,574.00

    PROTON NMR IMAGING IS RAPIDLY BECOMING A MAJOR DIAGNOSTIC TOOL IN HEALTH CARE. THE TECHNIQUE OFFERS HIGH RESOLUTION IMAGES WITHOUT THE USE OF IONIZING RADIATION. DIAGNOSTIC CAPABILITY CAN BE ENHANCED ...

    SBIR Phase II 1985 Department of Health and Human Services
  4. THE SITE SPECIFIC DELIVERY OF DRUGS TO IN VIVO SITES CAN INCREASE THE THERAPEUTIC EFFECTIVENESS OF DRUGS WHILE REDUCING NON-SPECIFIC TOXIC EFFECTS.

    Amount: $50,000.00

    THE SITE SPECIFIC DELIVERY OF DRUGS TO IN VIVO SITES CAN INCREASE THE THERAPEUTIC EFFECTIVENESS OF DRUGS WHILE REDUCING NON-SPECIFIC TOXIC EFFECTS. THE USE OF THERMOLABILE VESICLES FOR THE DELIVERY OF ...

    SBIR Phase I 1984 Department of Health and Human Services
  5. TARGET TO SPECIFIC LYMPHOID CELLS. PHASE I. MACROPHAGE TARGETING.

    Amount: $35,000.00

    A THREE PHASE PROJECT IS PROPOSED TO COMMERCIALIZE FORMULATIONS OF PHOSPHOLIPID VESICLES CAPABLE OF DELIVERING IMMUNOGENIC SUBSTANCES TO SPECIFIC LYMPHOID CELLS. PHASE I IS A PROOF OF CONCEPT STUDY DE ...

    SBIR Phase I 1983 National Science Foundation
  6. RECOMBINANT DNA TECHNOLOGY HAS PROVEN TO BE A POWERUL TOOL OF RESEARCH WITH POTENTIAL TO REVOLUTIONIZE AGRICULTURAL ANDMEDICAL PRACTICES.

    Amount: $35,000.00

    RECOMBINANT DNA TECHNOLOGY HAS PROVEN TO BE A POWERUL TOOL OF RESEARCH WITH POTENTIAL TO REVOLUTIONIZE AGRICULTURAL ANDMEDICAL PRACTICES. THE TECHNOLOGY, WHICH INVOLVES ISOLATINGA GENE SEQUENCE OF INT ...

    SBIR Phase I 1983 National Science Foundation
  7. MANY IMMUNOSTIMULATORY AGENTS ARE AVAILABLE WHICH ARE POTENTIAL MACROPHAGE ACTIVATING AGENTS.

    Amount: $49,938.00

    MANY IMMUNOSTIMULATORY AGENTS ARE AVAILABLE WHICH ARE POTENTIAL MACROPHAGE ACTIVATING AGENTS. HOWEVER, THEIR IN VIVO ABILITY TO INDUCE ANTITUMOR ACTIVITY IN MACROPHAGE IS SEVERELY LIMITED DUE TO THE R ...

    SBIR Phase I 1985 Department of Health and Human Services
  8. VESTAR RESEARCH INC.

    Amount: $49,019.00

    VESTAR RESEARCH INC. PROPOSES TO DEVELOP PHOSPHOLIPID VESICLE FORMULATIONS (LIPOSOMES) FOR INCORPORATION OF POORLY SOLUBLE AND/OR UNSTABLE ANTICANCER DRUGS INTO AQUEOUS MEDIA ACCEPTABLE FOR INTRAVENOU ...

    SBIR Phase I 1985 Department of Health and Human Services
  9. ACUTE MYOCARDIAL INFARCTION ACCOUNTS FOR APPROXIMATELY 700,000 HOSPITALIZATIONS ANNUALLY.

    Amount: $50,000.00

    ACUTE MYOCARDIAL INFARCTION ACCOUNTS FOR APPROXIMATELY 700,000 HOSPITALIZATIONS ANNUALLY. ONE THERAPEUTIC APPROACHTO THIS PROBLEM IS THE APPLICATION OF THROMBOLYTIC AGENTS, SUCH AS STREPTOKINASE, TO P ...

    SBIR Phase I 1986 Department of Health and Human Services
  10. LIPOSOME-ENCAPSULATED B-10 FOR NEUTRON CAPTURE THERAPY

    Amount: $50,000.00

    NEUTRON CAPTURE THERAPY IS AN ATTRACTIVE ALTERNATIVE TO STANDARD RADIATION TECHNIQUES FOR CANCER TREATMENT IF NUCLEI, SUCH AS (10)B, CAN BE SELECTIVELY CONCENTRATED IN TUMORS. SMALL, UNILAMELLAR, PHOS ...

    SBIR Phase I 1987 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government